BTIG analyst Thomas Shrader reiterates Serina Therapeutics (AMEX:SER) with a Buy and maintains $8 price target.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
Alpaca · SIPUpdated October 27 20:00 NY15 Minutes Delayed
Verizon CEO puts $500 billion price tag on Elon Musk's phone plan
Yahoo2 Hours Ago
Watsco, Inc. Enters into New $750.0 Million Credit Facility
Fintel2 Hours Ago
Dow Jones Futures Fall, Techs Rise As SK Hynix Crushes Views; Fed, Microsoft, Google On Deck
Yahoo2 Hours Ago
TSLA Stock Is October’s Mag 7 King — But 2 Motorcycle Stocks Race Past Tesla Even As Chinese EV Stocks See Red
Yahoo2 Hours Ago
Why Did XOM, BTE, VTRS Jump To 52-Week Highs Today?
Yahoo3 Hours Ago
